» Articles » PMID: 37569402

Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Aug 12
PMID 37569402
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial receptivity is a state of the endometrium defined by its readiness for embryo implantation. When the receptivity of the endometrium is impaired due to hyperandrogenism or androgen excess, this condition can lead to pregnancy loss or infertility. Hyperandrogenism encompasses a wide range of clinical manifestations, including polycystic ovary syndrome (PCOS), idiopathic hirsutism, hirsutism and hyperandrogaenemia, non-classical congenital adrenal hyperplasia, hyperandrogenism, insulin resistance, acanthosis nigricans (HAIR-AN), ovarian or adrenal androgen-secreting neoplasms, Cushing's syndrome, and hyperprolactinaemia. Recurrent miscarriages have been shown to be closely related to elevated testosterone levels, which alter the endometrial milieu so that it is less favourable for embryo implantation. There are mechanisms for endometrial receptivity that are affected by excess androgen. The HOXA gene, aVβ3 integrin, CDK signalling pathway, MECA-79, and MAGEA-11 were the genes and proteins affect endometrial receptivity in the presence of a hyperandrogenic state. In this review, we would like to explore the other manifestations of androgen excess focusing on causes other than PCOS and learn possible mechanisms of endometrial receptivity behind androgen excess leading to pregnancy loss or infertility.

Citing Articles

Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights.

Guo Y, Yang J, Chen H, Zhou Y, Yang Y, Wang B J Ovarian Res. 2025; 18(1):52.

PMID: 40075432 PMC: 11900192. DOI: 10.1186/s13048-025-01638-x.


Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity.

Yusuf A, Amri M, Ugusman A, A Hamid A, Abd Rahman I, Mokhtar M Biomedicines. 2025; 13(2).

PMID: 40002703 PMC: 11853574. DOI: 10.3390/biomedicines13020289.


The Interplay of Uterine Health and Obesity: A Comprehensive Review.

Sisljagic D, Blazetic S, Heffer M, Vranjes Delac M, Muller A Biomedicines. 2025; 12(12.

PMID: 39767708 PMC: 11673887. DOI: 10.3390/biomedicines12122801.


ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.

Vaiarelli A, Cimadomo D, Rucci C, Innocenti F, Taggi M, Pittana E J Assist Reprod Genet. 2024; 41(12):3423-3432.

PMID: 39495342 PMC: 11707217. DOI: 10.1007/s10815-024-03299-z.


Diacerein and myo-inositol alleviate letrozole-induced PCOS via modulation of HMGB1, SIRT1, and NF-kB: A comparative study.

Khodir S, Sweed E, Motawea S, Al-Gholam M, Sobhy Elnaidany S, Dayer M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39432066 DOI: 10.1007/s00210-024-03497-7.


References
1.
Craciunas L, Gallos I, Chu J, Bourne T, Quenby S, Brosens J . Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Hum Reprod Update. 2019; 25(2):202-223. DOI: 10.1093/humupd/dmy044. View

2.
Nijkang N, Anderson L, Markham R, Manconi F . Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med. 2019; 7:2050312119848247. PMC: 6501471. DOI: 10.1177/2050312119848247. View

3.
Ur Rahman T, Ullah K, Guo M, Pan H, Liu J, Ren J . Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages. Oncotarget. 2018; 9(37):24627-24641. PMC: 5973874. DOI: 10.18632/oncotarget.24821. View

4.
Armengaud J, Charkaluk M, Trivin C, Tardy V, Breart G, Brauner R . Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab. 2009; 94(8):2835-40. DOI: 10.1210/jc.2009-0314. View

5.
GORDON G, SOUTHREN A, Tochimoto S, Rand J, OLIVO J . Effect of hyperthyroidism and hypothyroidism on the metabolism of testosterone and androstenedione in man. J Clin Endocrinol Metab. 1969; 29(2):164-70. DOI: 10.1210/jcem-29-2-164. View